NCT03709459View on ClinicalTrials.gov

Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and Chlamydia

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

July 17, 2024

Study Completion Date

December 17, 2024

Conditions
STIs Prevention
Interventions
DRUG

Doxycycline

Participants will be asked to take Doxycycline 100mg/day for 12months duration

Trial Locations (4)

2000

Sydney Sexual Health Centre, Sydney

2010

Kirketon Road Centre, Sydney

2050

Royal Prince Alfred Hospital Sexual Health Medicine, Camperdown

3053

Melbourne Sexual Health Centre, Melbourne

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
collaborator

South Australian Health and Medical Research Institute

OTHER

collaborator

Monash University

OTHER

lead

Kirby Institute

OTHER_GOV

NCT03709459 - Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and Chlamydia | Biotech Hunter | Biotech Hunter